Preprint · OA
via OpenAlex
Transient Reprogramming of Neonatal Cardiomyocytes to a Proliferative Dedifferentiated State
Thomas Kisby, Irene de Lázaro, Maria Stylianou, Giulio Cossu, Kostas Kostarelos
bioRxiv (Cold Spring Harbor Laboratory) · 2019
Stem-cell exhaustion
Gene therapy
Partial reprogramming (OSK)
Cell culture / in vitro
Rat
Zebrafish
In vitro
Abstract
Abstract Zebrafish and urodele amphibians are capable of extraordinary myocardial regeneration thanks to the ability of their cardiomyocytes to undergo transient dedifferentiation and proliferation. Somatic cells can be temporarily reprogrammed to a proliferative, dedifferentiated state through transient expression of Oct3/4, Sox2, Klf4 and c-Myc (OSKM) transcription factors. Here, we utilized an OSKM-encoding non-integrating vector to induce transient reprogramming of mammalian cardiomyocytes in vitro . Reprogramming factor expression in neonatal rat cardiomyocytes triggered rapid cell dedifferentiation characterized by downregulation of cardiomyocyte specific gene and protein expression, sarcomere dis-assembly and loss of autorhythmic contractile activity. Concomitantly, a significant increase in cell cycle related gene expression and Ki67 positive cells was observed, indicating that dedifferentiated cardiomyocytes possess an enhanced proliferative capacity. A small proportion of cardiomyocytes progressed through mesenchymal to epithelial transition, further indicating the initiation of cell reprogramming. However, complete reprogramming to a pluripotent-like state was not achieved for the duration of the study (20 days), both in standard and embryonic stem cell culture media conditions. The transient nature of this partial reprogramming(definition) response was confirmed as cardiomyocyte-specific cell morphology, gene expression and contractile activity were recovered by day 15 after viral transduction. Further investigations into the complete downstream biological effects of ectopic OSKM expression in cardiomyocytes and the fate of these reprogrammed cells are warranted. Our results to date suggest that transient reprogramming could be a feasible strategy to recapitulate regenerative mechanisms of lower vertebrates and inform direct gene therapy approaches to cardiac regenerative medicine.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1101/801092
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
Kisby, T., Lázaro, I.D., Stylianou, M., Cossu, G., & Kostarelos, K. (2019). Transient Reprogramming of Neonatal Cardiomyocytes to a Proliferative Dedifferentiated State. <em>bioRxiv (Cold Spring Harbor Laboratory)</em>. https://doi.org/10.1101/801092
Vancouver
Kisby T, Lázaro ID, Stylianou M, Cossu G, Kostarelos K. Transient Reprogramming of Neonatal Cardiomyocytes to a Proliferative Dedifferentiated State. bioRxiv (Cold Spring Harbor Laboratory). 2019. doi:10.1101/801092.
BibTeX
@unpublished{thomas2019Transi,
title = {Transient Reprogramming of Neonatal Cardiomyocytes to a Proliferative Dedifferentiated State},
author = {Thomas Kisby and Irene de Lázaro and Maria Stylianou and Giulio Cossu and Kostas Kostarelos},
journal = {bioRxiv (Cold Spring Harbor Laboratory)},
year = {2019},
doi = {10.1101/801092},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2021
Open access · CC-BY
Transient reprogramming of postnatal cardiomyocytes to a dedifferentiated state
bioRxiv (Cold Spring Harbor Laboratory) 2021
Preprint · OA
Partial reprogramming restores youthful gene expression through transient suppression of cell identity
Current Gene Therapy 2019
Preprint · CC-BY
Partial Reprogramming As An Emerging Strategy for Safe Induced Cell Generation and Rejuvenation
Science Advances 2022
Open access · CC-BY
Intermediate cells of in vitro cellular reprogramming and in vivo tissue regeneration require desmoplakin
Aging Cell 2023
Open access · CC-BY
Rutin is a potent senomorphic agent to target senescent cells and can improve chemotherapeutic efficacy
Advanced Therapeutics 2020
Open access · CC-BY